Xiaoyaosan Alleviates Hippocampal Glutamate-Induced Toxicity in the CUMS Rats via NR2B and PI3K/Akt Signaling Pathway.

Zhou, Xue-Ming; Liu, Chen-Yue; Liu, Yue-Yun; Ma, Qing-Yu; Zhao, Xin; Jiang, You-Ming; Li, Xiao-Juan; Chen, Jia-Xu

Zhou, Xue-Ming; Liu, Chen-Yue; Liu, Yue-Yun; Ma, Qing-Yu; Zhao, Xin; Jiang, You-Ming; Li, Xiao-Juan; Chen, Jia-Xu.

Afiliação

Zhou XM; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Liu CY; School of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Haerbin, China.
Liu YY; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Ma QY; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zhao X; Formula-Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Jiang YM; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Li XJ; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Chen JX; Formula-Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Front Pharmacol ; 12: 586788, 2021.

Article em En | MEDLINE | ID: mdl-33912031

Palavras-chave

NR2B, PI3K/Akt pathway; depression; glutamate; hippocampal CA1 region; xiaoyaosan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google